hydroxyurea has been researched along with Bilirubinemia in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"This study aims to determine the maximum tolerated dose (MTD) of clofarabine combined with the EORTC-GIMEMA 3 + 10 induction regimen (idarubicin + cytosine arabinoside) in adults with untreated acute myelogenous leukemia or high-risk myelodysplastic syndrome." | 9.19 | Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): p ( Amadori, S; de Witte, T; Halkes, CJ; Karrasch, M; Marie, JP; Meert, L; Meloni, G; Muus, P; Rapion, J; Suciu, S; Vignetti, M; Willemze, R, 2014) |
"This study aims to determine the maximum tolerated dose (MTD) of clofarabine combined with the EORTC-GIMEMA 3 + 10 induction regimen (idarubicin + cytosine arabinoside) in adults with untreated acute myelogenous leukemia or high-risk myelodysplastic syndrome." | 5.19 | Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): p ( Amadori, S; de Witte, T; Halkes, CJ; Karrasch, M; Marie, JP; Meert, L; Meloni, G; Muus, P; Rapion, J; Suciu, S; Vignetti, M; Willemze, R, 2014) |
" Black pigment gallstones caused by elevated bilirubin excretion are common." | 4.86 | Gastrointestinal and hepatic complications of sickle cell disease. ( Ebert, EC; Hagspiel, KD; Nagar, M, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Willemze, R | 1 |
Suciu, S | 1 |
Muus, P | 1 |
Halkes, CJ | 1 |
Meloni, G | 1 |
Meert, L | 1 |
Karrasch, M | 1 |
Rapion, J | 1 |
Vignetti, M | 1 |
Amadori, S | 1 |
de Witte, T | 1 |
Marie, JP | 1 |
Ebert, EC | 1 |
Nagar, M | 1 |
Hagspiel, KD | 1 |
1 review available for hydroxyurea and Bilirubinemia
Article | Year |
---|---|
Gastrointestinal and hepatic complications of sickle cell disease.
Topics: Anemia; Anemia, Sickle Cell; Antisickling Agents; Bilirubin; Blood Transfusion; Gallstones; Humans; | 2010 |
1 trial available for hydroxyurea and Bilirubinemia
Article | Year |
---|---|
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): p
Topics: Adenine Nucleotides; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides | 2014 |